The sheer volume of contrast media used in medical imaging is staggering, and it's raising serious environmental concerns. From 2011 to 2024, a massive 13.5 billion milliliters (mL) of contrast media were administered to Medicare beneficiaries. This was used for a staggering 169 million advanced imaging exams, like CT and MRI scans, as revealed in a recent research letter published in JAMA Network Open. But here's where it gets controversial: these essential tools for diagnosis may be causing more harm than good to our planet.
Lead author Dr. Florence Doo from the University of Maryland, along with colleagues from the Harvey L. Neiman Health Policy Institute (HPI), NYU Langone, and institutions in the UK, highlighted a critical issue: contrast agents, while necessary for effective imaging, don't simply vanish after use.
"Contrast agents are necessary for effective imaging, but they don't disappear after use," Dr. Doo stated. "Iodine and gadolinium are non-renewable resources that can enter wastewater and accumulate in rivers, oceans, and even drinking water. Quantifying which imaging exams use the most contrast helps us [develop] thoughtful, practical contrast stewardship strategies to ensure patients continue to receive safe and high-quality imaging care."
These agents, crucial for diagnosing diseases, are also persistent pollutants. Standard wastewater treatment doesn't fully remove them, leading to worries about their long-term impact on the environment and public health.
The study examined U.S. Medicare Part B data from 2011 to 2024, identifying imaging procedures using contrast agents (CT, MRI, etc.). They estimated contrast volumes using standard doses: 100 mL for iodinated agents and 15 mL for gadolinium-based agents.
During the study period, Medicare beneficiaries underwent 169 million contrast-enhanced imaging exams across 82 procedure codes. These scans required 13.5 billion mL of contrast media. The data revealed some interesting trends:
- Iodinated agents dominated the total volume, accounting for 12.9 billion mL (95.6%).
- The CT abdomen or pelvis was the single largest contributor to contrast use, at 4.4 billion mL.
- For gadolinium agents, brain MRI was the top consumer, at 221 million mL.
- Annual contrast volume increased overall, with an average growth of 5.2% per year for iodinated agents and 3.5% for gadolinium agents between 2014 and 2019. (The COVID-19 pandemic caused a dip in 2020, followed by rebounds in 2021.)
Dr. Doo's team emphasizes "actionable mitigation strategies" to reduce environmental pollution, including:
- Confirming the clinical appropriateness of imaging orders.
- Using weight-based dosing to avoid excess contrast.
- Employing multiuse vial systems.
They also mentioned that biodegradable contrast alternatives and AI reduction algorithms are emerging, although these methods still require more evaluation.
And this is the part most people miss... The findings paint a stark picture of medical imaging's environmental impact. Dr. Doo stated, "We can't ignore the environmental consequences of medical imaging. Stewardship of contrast agents is a measurable and impactful way to align patient care with planetary health and should be an important part of broader health care sustainability efforts."
What are your thoughts? Do you think the medical community is doing enough to address the environmental impact of contrast agents? Share your opinions in the comments below!
